
Orthofix Medical Inc.
- Jurisdiction
United States - ISIN
US68752M1080 (OFIX )- Sectors
Scores
- Fair value (Benjamin Graham formula)
- N/A
- Financial strength (Piotroski F-Value)
-
5
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
4
/ 7
Profile
Orthofix Medical Inc. operates as a medical device and biologics company in the United States, Italy, Germany, France, the United Kingdom, Brazil, and internationally. Read full profile
Fundamentals
- Net revenue
€690.06M - Gross margin
66.8% - EBIT
-€81.25M - EBIT margin
-11.8% - Net income
-€105.52M - Net margin
-15.3%
Statement period: - (published )
Estimates
Fiscal Year | Net revenue | Net income |
---|---|---|
| N/A | |
N/A | N/A | |
N/A | N/A |
Stock price
Dividends
No dividend payouts
Analyst ratings
No analyst ratings available
Insider Transactions
Name | Title | Transaction Date | Shares | Price | Value |
---|---|---|---|---|---|
Fisher Patrick | President, Global Orthopedics |
|
|
|
|
Earnings Calls
Investor transactions
Name | Shares | Value | Last change | Change type |
---|---|---|---|---|
Peter Brown |
|
|
|
Buy |
Earnings Calls
Latest earnings call: May 7, 2024 (Q1 2024)